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Abstract
Objectives The global burden of asbestos-related
diseases (ARDs) is significant, and most of the world’s
population live in countries where asbestos use
continues. We examined the gaps between ARD research
and suggestions of WHO and the International Labour
Organization on prevention.
Methods From the Web of Science, we collected data
on all articles published during 1991–2016 and identified
a subset of ARD-related articles. We classified articles
into three research areas—laboratory, clinical and public
health—and examined their time trends. For all and the
top 11 countries publishing ARD-related articles, we
calculated the proportions of all ARD-related articles that
were in each of the three areas, the average rates of ARDrelated articles over all articles, and the average annual
per cent changes of rates.
Results ARD-related articles (n=14 284) accounted for
1.3‰ of all articles in 1991, but this had declined to 0.8‰
by 2016. Among the three research areas, the clinical area
accounted for the largest proportion (65.0%), followed by
laboratory (26.5%) and public health (24.9%). The public
health area declined faster than the other areas, at −5.7%
per year. Discrepancies were also observed among the
top 11 countries regarding emphasis on public health
research, with Finland and Italy having higher, and China
and the Netherlands lower, emphases.
Conclusions There is declining emphasis on the public
health area in the ARD-related literature. Under the
ongoing global situation of ARD, primary prevention will
remain key for some time, warranting efforts to rectify the
current trend in ARD-related research.

Introduction
WHO and the International Labour Organization (ILO) have repeatedly stated that
the best way to eliminate asbestos-related
diseases (ARDs) is for countries to stop using
asbestos.1–3 Although more than 60 countries
have banned partial or all use of asbestos,4 the
majority of the world’s population currently
live in countries with ongoing asbestos
consumption.5 In 2015, asbestos was mined in
five countries, while in 2014 at least 30 countries imported raw asbestos, and presumably a
much larger number of countries consumed

Strengths and limitations of this study
►► The main strength of the study is that it contributes

to the estimation of relative gaps of research focus
in asbestos and asbestos-related diseases globally
using a longitudinal analysis.
►► We comprehensively collected data on the number
of articles published during 1991–2016, classified
252 subject categories into three research areas,
and assigned each article into these research areas,
respectively.
►► The 26-year data showed the number of articles increased over the last quarter century, but the expansion has lagged behind that of the entire scientific
literature.
►► Although the data were extracted for all countries
with available data, countries that have limited publications might be under-represented.
►► Other asbestos-related diseases might be under-represented in our analysis due to our selection
criteria for articles.

asbestos-containing products.6 A recent
Global Burden of Diseases (GBDs) study estimated that in 2016 more than 222 000 deaths
were attributable to occupational exposure
to asbestos.7 ARDs, including asbestos-related cancers such as mesothelioma and lung
cancer,8 are caused by occupational as well
as environmental exposure to asbestos.2 The
incidence rates of ARD are expected to peak
in the coming decades as a consequence of
past and ongoing exposure to asbestos as well
as the long latency period between exposure
and disease development.2 9 Odgerel et al
recently have shown that the GBD estimates
may still be significantly underestimated.8
Tackling the burden of ARD requires policies based on sound scientific knowledge.10
Relevant and high-quality research on asbestos
and ARDs should provide the evidence base
required for the prevention of asbestos
exposure, clinical intervention, patient care
and policy-making.5 11 12 Although the scientific community has long been engaged in
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Methods
Data source
We searched for ARD-related publications in the database
‘Web of Science Core Collection’ on the Web of Science
platform (Clarivate Analytics) by using the keywords
‘asbestos’ OR ‘mesothelioma’. We entered our keywords
under the search field ‘Topic’, which includes Title,
Abstract, Author Keywords and Keywords Plus on the
Web of Science platform.16 The inclusion criteria were
original scientific articles or reviews (articles, hereinafter)
and year of publication during 1991–2016. We chose this
period for two reasons. First, the International Classification of Diseases 10th version (ICD-10), which assigned
the code C45 to ‘malignant mesothelioma’, was endorsed
by the 43rd World Health Assembly in 1990. Second, the
yearly number of ARD-related articles increased markedly
after 1991.17 Data obtained from the Web of Science were
imported into the InCites (Clarivate Analytics) tool for
further grouping and analyses.17
Group definition and process
To assess the trends of ARD-related research in specific
research fields, we classified the Web of Science’s 252
subject categories into three areas:18 (1) laboratory:
including toxicology, cell biology, biochemistry and
molecular biology, etc; (2) clinical: including oncology,
respiratory system, pathology, etc; (3) public health:
including public, environmental and occupational health,
environmental sciences, environmental engineering, etc
2

and (4) irrelevant: not (1, 2) or (3).18 There are three
premises to assign each article to relevant subject categories. First, each article was published in only one journal.
Second, each journal, according to the design of the Web
of Science platform, can be assigned to one or more relevant subject categories.18 Third, each category, according
to our grouping approach, can be assigned to only one
research area. Hence, according to above three premises, each article was assigned by the Web of Science to
a single or multiple subject categories, but each category
was classified to only one research area. This allowed us to
use the Web of Science’s 252 subject categories as surrogate indicators of the research focus of each article.18 We
assigned these subject categories to the three research
areas via a three-step process. First, two researchers
independently classified the 252 subject categories into
the three areas with 72% (n=182) agreement. Second,
a senior rater independently assigned the categories to
the three areas with no knowledge of the assignments
of the two researchers for the disputed cases (n=70)
and then reached 96% agreement (n=243). Finally, for
the remaining 4% (n=9) of subject categories without
agreement, the three researchers discussed each subject
category and reached a consensus on the area to which it
should be assigned. Articles in research areas (1 , 2) and
(3) were extracted for further analyses. The assignments
of the subject categories to the three areas are listed in
online supplementary file, table S1, including laboratory
(n=22), clinical (n=38) and public health (n=32).
Analysis
We calculated the numbers and proportions of ARD-related articles in each research area for all countries and
for the top 11 countries. These 11 countries accounted
for 83.0% of ARD-related articles during 1991–2016.
We treated all articles in research areas (1, 2) and (3) in
InCites as a reference group.
To estimate the linear trend of ARD-related articles
over time, we applied the joinpoint regression modelling
approach to consider the years with significant joinpoints
(the maximum number of nodes was two in each model)
and calculated the average annual per cent change
(AAPC, a weighted average of yearly change),19 by fitting
a log-linear regression:
(
)
()
ln
 publication rate = β0 + β1 × t 
where t denotes the calendar time, from 1 for the year
of 1991 to 26 for the year of 2016, and β0 and β1 denote
the intercept and slope. We further applied a generalised
additive mixed model to examine the intercountry variations in the rate of ARD-related articles relative to all
articles.20 We adjusted for per capita asbestos consumption (defined as the volume of asbestos production and
importation divided by the total population in each
year)21 22 and the age-adjusted mortality rate of mesothelioma (calculated by dividing the number of mesothelioma deaths (C45 in ICD-10) of 5-year age groups
by the population of corresponding age groups in each
Lin R-T, et al. BMJ Open 2018;8:e022806. doi:10.1136/bmjopen-2018-022806
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research on a wide spectrum of themes related to asbestos
and ARDs, resulting in many publications (ARD-related
articles, hereinafter), the extent to which such research
aligns with societal priorities reflected in the WHO/ILO
statements is unclear. Moreover, variations in the topics
addressed in ARD-related articles in relevant research
among countries and over time is a separate, but related
theme of interest. Bibliometric analysis of the global
ARD-related literature could shed light on the quantity
(or ‘number’) and the quality (or ‘articles published in a
specific research area’).13 The results of such an analysis
may also assist in optimising resource allocation and the
translation of research into policy.
The ongoing global situation in relation to ARDs and
the WHO/ILO statements lend support to the notion
that public health and disease prevention should be
areas of high priority in research on ARDs.1–3 Although
the overall trends in the mesothelioma literature have
been analysed in previous studies,14 15 to date no analysis of the ARD-related literature has been conducted
aimed at elucidating the research priorities in previous
works while accounting for the different areas of scientific
expertise. Therefore, the objectives of this study were to
describe trends in ARD-related research with an emphasis
on the area of public health and intercountry variations
by analysing the numbers and research areas of articles
published during 1991–2016.

Open access

ASB + XMOR + offset 
ln(µ
it ) = α + αi + f(t) + Xit
it



where α and αi denote the fixed and random interASB
MOR
cepts. X
 it  and X
 it  represent asbestos consumption
and the age-adjusted rate of mortality from mesothelioma
in country i at time t. A cubic spline f(t) was included to
control for temporal autocorrelation. Offset denotes the
natural logarithm of all articles in each country per year.
The final model for each research area only included
covariates that were significantly associated with ARD-related articles. We performed the statistical analyses using
Joinpoint Regression Program V.4.5.0.1 (National Cancer
Institute, USA) and R studio V.1.0.143 (R Foundation for
Statistical Computing, Austria). The significance level was
set at 5%.23
Patient and public involvement
No patients and or public were involved in this study.

Results
We identified 15 405 ARD-related articles published
during 1991–2016 in the Web of Science, of which 14 284
had information regarding the year of publication, the
country of authors and the subject categories to analyse
using InCites for categorisation into the three research
areas (see online supplementary file, table S1).
As shown in figure 1, both the total number of scientific
articles and the number of ARD-related articles increased
during 1991–2016, but the proportions of all articles that

were ARD-related decreased, from 1.3‰ (proportion
multiplied by 1000) in 1991 to 0.8‰ in 2016.
Figure 2 shows the trends in the proportions of articles
that were in each of the three research areas among all
and ARD-related articles during 1991–2016. Note that, in
each year, the sum of the proportions of the three areas
exceeded 100% because each article could be classified
into more than one area. Among all articles, the proportion in the public health area grew over the study period to
narrow the gap with the other two other areas (figure 2A).
In contrast, for ARD-related articles, the proportion in
the public health area fluctuated but steadily decreased
(from 39.3% in 1991 to 22.5% in 2016), whereas the
proportion in the clinical area fluctuated but generally
increased and that in the laboratory area fluctuated with
no discernible trend (figure 2B).
Among all ARD-related articles published in all countries during 1991–2016, the clinical area accounted for
the largest proportion (65.0%), followed by the laboratory (26.5%) and public health (24.9%) areas (table 1).
In terms of the rate of ARD-related articles relative to all
articles, the clinical area was the highest (1.3‰/year),
followed by the public health (0.8‰/year) and laboratory
(0.6‰/year) areas. The AAPC of ARD-related articles
relative to all articles was negative with no statistical significance for the clinical area (−0.1 (95% CI −0.5 to 0.4)%/
year), and negative with statistical significance for the
public health (−5.7 (95% CI −7.6 to −3.8)%/year) and
laboratory (−1.1 (95% CI −2.0 to −0.3)%/year) areas.
When ARD-related articles from the top 11 countries
were analysed, similar patterns were observed to those
found for all countries. However, distinctive patterns
emerged when the 11 top countries were examined individually. In terms of relative proportions, the clinical area
was dominant in all 11 countries, with Australia showing

Figure 1 Trend in the number and proportion of scientific articles from 1991 to 2016. ARD-related articles=articles with a
theme of asbestos and ARDs. Articles were defined as articles or reviews belonging to any of the three research areas (see
online supplementary file, table S1) in InCites (Clarivate Analytics).17 ARD, asbestos-related diseases.
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year during 1995–2013, weighted by the world standard
population).8 Y it  was defined as the number of ARD-related articles in county i at calendar time t, which follows
a Poisson distribution with a mean parameter µit . The
model equation can be expressed as follows:
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the highest proportion (75.0%) and Canada the lowest
(56.2%). When the areas of public health and laboratory
were compared, seven countries had higher proportions
for laboratory and four countries had higher proportions for public health. In terms of rate, 9 out of the 11
countries had the highest rates of ARD-related articles for
the clinical area among the three areas, led by Australia
(2.2‰/year). In the public health area, Finland and Italy
had the highest rates of ARD-related articles (4.2‰/
year and 2.8‰/year, respectively), while the Netherlands
4

and China had the lowest (0.5‰/year and 0.6‰/year,
respectively).
In terms of the AAPC of ARD-related relative to all articles among the top 11 countries (see online supplementary file, figure S1), the clinical area showed statistically
significant increases in two countries, specifically, Japan
(4.3 (95% CI 0.5 to 8.3)%/year) and Italy (2.6 (95% CI
1.6 to 3.6)%/year), but statistically significant decreases
in five countries. Similarly, the laboratory area showed
statistically significant increases in Japan (5.9 (95% CI
Lin R-T, et al. BMJ Open 2018;8:e022806. doi:10.1136/bmjopen-2018-022806
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Figure 2 Trend in the number and proportion of articles by research area. ARD-related publications=articles with a
theme of asbestos and ARDs. Articles were defined as articles or reviews belonging to any of three research areas (see
online supplementary file, table S1) in InCites (Clarivate Analytics).17 ARD, asbestos-related diseases.
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ARD-related articles=articles with a theme of asbestos and asbestos-related diseases. Articles were defined as articles or reviews belonging to any of three research areas (see
online supplementary file, table S1) in InCites (Clarivate Analytics).17
*n=Number of articles. Each article may be assigned to more than one research area and country. Duplicates were excluded when the three areas were combined.
†Rate (unit: ‰ per year) was calculated by first dividing the number of asbestos-related articles (area-specific and three areas combined) by the total number of scientific articles (area-specific
and three areas combined) for each year, and then averaging the results over 26 years and multiplying by 1000 (thus, the unit is ‰ per year, which is a rate rather than a proportion).
‡AAPC=average annual per cent change (unit: % per year). AAPC is a summary measure of the trend over the study period of 1991–2016, which was calculated as the average % change
per year of the proportion of asbestos-related articles relative to all articles (area-specific and three areas combined) during the study period, weighted by the interval length of each annual
per cent change, using joinpoint regression modelling.19
§Proportion (unit: %) was calculated by dividing the number of area-specific asbestos-related articles by the number of three areas combined asbestos-related articles over 26 years. Because
the sum of the number of articles in the three research areas exceeded that of the three areas combined, the sum of the proportions of the three research areas may exceed 100%.
¶P value <0.05.
ARD, asbestos-related diseases.
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3.4 to 8.4)%/year) and Italy (4.3 (95% CI 2.9 to 5.7)%/
year), but statistically significant decreases in five countries. The public health area decreased in all 11 countries,
with statistical significance in nine countries, led by China
(−13.5 (95% CI −16.2 to 10.7)%/year).
Figure 3 compares the top 11 countries in terms of the
rate ratio of the public health area in ARD-related articles, after adjusting for temporal variation. (Note that
asbestos consumption and age-adjusted mortality rate of
mesothelioma were not statistically significant predictors
of an article being in the public health area, and were
thus excluded from the final model.) Compared with
the average rate across the 11 countries, Finland and
Italy showed significantly higher rate ratios by 3.40-fold
(95% CI 1.95 to 5.92) and 3.39-fold (95% CI 2.00 to 5.74),
respectively. In contrast, China showed a significantly
lower rate ratio by 0.25-fold (95% CI 0.14 to 0.45). The
Netherlands had the second lowest rate ratio, but it did
not reach statistical significance at 0.56-fold (95% CI 0.31
to 1.02).
Discussion
Our analysis of trends in scientific articles published
throughout the world between 1991 and 2016 revealed
that the growth of ARD-related articles published lagged
considerably behind that of the overall scientific output.
We further examined the proportions of papers published
in three research areas of interest—public health, laboratory and clinical—both in the entire and ARD-related
literature. We found that, in the entire literature, the
6

proportion of papers with a public health orientation was
initially much lower than those of laboratory and clinical,
but that during the study period the proportion of public
health-oriented papers grew, narrowing the gap among
the three areas. When we analysed only the ARD-related
literature, by contrast, the public health area did not keep
up with the clinical area and criss-crossed with the laboratory area. Although the clinical area was consistently dominant, individual countries showed distinct patterns in the
proportions of articles in the three research areas and the
trends in those proportions over time. Overall, the presence of ARD-related articles has been weakening in the
scientific literature, which was enhanced by a decline in
emphasis on public health in ARD-related research. This
raises serious concerns in view of the ongoing relevant
global situation and the WHO/ILO declarations.2 3
ARD is increasingly recognised as a global health issue,
where a variety of unmet needs require multidisciplinary
cooperation on a global scale.5 9 WHO has been joined by
the ILO to emphasise that implementing public health
measures is the most effective approach to eliminating
ARD.2 3 24 This is plausible as the majority of ARD cases
are reported in developed countries that already have
an asbestos ban, but an estimated 125 million people,
primarily in low/middle-income countries, continue to
be occupationally exposed to asbestos.2 These countries
typically lack the medico-social infrastructure to prevent
asbestos exposure and to deal adequately with patients,
including diagnosis, treatment, care and compensation. The relevant experience and expertise acquired by
Lin R-T, et al. BMJ Open 2018;8:e022806. doi:10.1136/bmjopen-2018-022806
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Figure 3 Rate ratio of ARD-related articles in the public health area in each of the top 11 publishing countries compared
with the average for the top 11 countries ARD-related articles=articles with a theme of asbestos and ARDs. Red dotted line
represents the average of the top 11 countries. The rate ratio was estimated using a generalised additive mixed model with a
Poisson distribution by comparing the rate of the public health area of ARD-related articles of each country to the average rate
of the public health area of asbestos-related articles in these 11 countries (rate ratio=1), after adjusting for temporal variation.
Other covariates, specifically asbestos consumption and age-adjusted mortality rate of mesothelioma, were not included in the
final model because they did not reach statistical significance. ARD, asbestos-related disease.
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to assess the funding situations of ARD-related research
and how they relate to research areas.
Although the rate of articles published in the ARD-related literature in the public heath area consistently
declined across the top 11 countries, Finland and
Italy maintained a greater emphasis on public health
research, whereas China and the Netherlands had the
least emphasis. We speculate that the following factors
may have been in play. Previous studies have highlighted
that Nordic countries had more publications in occupational and environmental health compared with other
European countries.32 Finland has been the dominant
country in occupational and environmental health
research (accounting for 28% of public health research
in Finland vis-à-vis 11% in the Netherlands and 8% in the
UK).32 In addition, the Finnish Institute of Occupational
Health implemented many initiatives to address the
global asbestos/ARD situation, including international
conferences that formulated the Helsinki Criteria.33 34
In Italy, since the banning of asbestos in 1992, nationwide recognition grew regarding the need to initiate a
permanent surveillance system for mesothelioma, which
culminated in the establishment of the National Register
of Malignant Mesothelioma in 2002.35 This had the additional effect of promoting research,35 most likely in the
public health area. In China, researchers may be less
incentivised to conduct ARD-related research, particularly on the public health aspect, as it is a country where
the production and consumption of asbestos remain
rampant, with government oversight. The Netherlands
accelerated translational research in medicine (ie, from
bench to bedside), to become the central hub of European Advanced Translational Research Infrastructure in
Medicine integrating basic and clinical research. This
may have shifted emphasis away from public health to the
laboratory and clinical areas.
The present study had several limitations. First, we
classified research into three areas based on the subject
categories provided by the Web of Science,18 which may
have led to misclassifications. For example, some laboratory studies may have been conducted in the context
of public health research, but our method was unable to
discern context. Each article may also be assigned to more
than one country because the article was contributed by
authors from different countries. However, any misclassification bias will have been reduced by the capacity of
our method to assign each article to multiple categories and to multiple countries. An inevitable side effect,
however, was that the sum of the number of articles in
the three research areas exceeded that of the three areas
combined. Similarly, the sum of the number of articles
for each country exceeded that of all countries. Second,
when making longitudinal comparisons, we focused on
countries that have published higher numbers of ARD-related articles. However, the ARD burden will eventually
shift to low/middle-income countries that currently use
asbestos. In those countries, low numbers of ARD-related
articles were published during the study period, which
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developed countries have yet to be shared with the countries that are in need. Our findings in regard to the trends
in ARD-related research, specifically the slow growth of
ARD-related research in general and a lack of emphasis
on the public health area in particular, indicate a failure
to support the global health cause and the WHO/ILO
positions.
Our analysis showed that ARD-related research has
recently been gravitating towards the clinical area. This
is corroborated by an earlier study which found an association between ARD-related research output and national
burden of mesothelioma, although that study did not
differentiate between research areas.15 We found that
countries with higher age-adjusted rates of mortality from
mesothelioma had higher numbers of ARD-related articles, but only for the clinical area and the three areas
combined (data not shown). In addition, our selection
criteria of ARD-related articles (ie, ‘asbestos’ OR ‘mesothelioma’) likely increased the proportion of articles with
a clinical emphasis. A preponderance of clinical papers
may be explained by the important themes explored
in clinical ARD-related research, such as methods for
improving the diagnosis and treatment of patients. Moreover, the proportion of clinical papers may be inflated
by many papers in the laboratory area having a clinical
aspect, but not vice versa. That is, ARD-related laboratory
research addressing important themes, such as improving
our understanding of the disease mechanism, may be
conducted in the context of clinical and/or public health
research. Moreover, the laboratory area is probably driven
in tandem with the clinical area by the growing emphasis
on translational research in which laboratory work is positioned as ‘preclinical.’
A key factor that may support or impede the growth of
ARD-related research in the public health area is funding
due to its known substantial impact on the quantity and
quality of scientific articles. For example, austerity policies on public health in general can also impact public
health research. Funding agencies usually allocate a
larger portion of funding to emerging challenges or
high priority research programmes that are in line with
their policy direction.25 The majority of research funding
comes from governments,26 but diverse funding structures among countries lead to different research agendas
in public health.27 For example, in most countries in the
European Union, the Ministry of Science or Ministry
of Education is the primary funding agency for public
health research.27 Funding of medical research can cover
the public health area, but public health usually accounts
for only a small portion of the entire medical research
budget.27 The lack of national public health research strategies when allocating funds or unsustainable investment
in public health research could downplay the importance
of public health science.28 Furthermore, the capacity of
national insurance system to detect and deal with ARD is
an important factor,29–31 whereby a limited capacity will
obstruct visibility in the public arena, the public agenda
and hence public funding. Further research is warranted

Open access

Conclusion
In conclusion, the present analysis found that the proportion of the overall scientific literature that is ARD-related
has declined substantially over the last quarter century,
and that this decline was enhanced by a decrease in
emphasis on public health, although with notable intercountry variations. The future direction of ARD-related research warrants a review in consideration of the
ongoing situation on asbestos and foreseeable situation
for ARD reflected in the pertinent WHO/ILO recommendations. Setting research priorities with improved
emphasis on public health is essential to fill the gaps in
research on ARD.
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